Dr. Nir Barzilai, Ingeborg and Ira Leon Rennert Chair in Aging Research, director, Institute for Aging Research, Einstein, discusses his upcoming study of metformin (a drug traditionally used for diabetes) to see if age-related conditions, including cardiovascular, cancer and cognitive decline, are preventable.